Canada Immunoassay Development is a Canada -based biotech company focusing on lateral flow immunoassay device development and production, recombinant protein and antibody preparation.
Contract service is our business extension, including OEM products of lateral flow immunoassay devices, new rapid test device development starting from recombinant antigen design or antibody preparation to finished products.
We also supply contract service for research area for new recombinant protein and antibody development and production to explore our unknown world.
1. Lateral flow immunoassay devices
* Early dengue IgM and dengue IgG rapid test device
* Dengue NS1 antigen rapid test device
* HCV antibody rapid test device
* Mycoplasma pneumonia IgG/IgM rapid trst device
2. Antigens for lateral flow immunoassay devices
* Dengue subtype 1/2/ antigens for dengue IgG/IgM rapid test product
* Chimeric HCV antigen (core-NS3-NS4-NS5)
* Mycoplasma pneumonia antigen
3. Dengue NS1 antibodies for dengue NS1 antigen rapid test
* Two dengue NS1 antibodies were identified and used in dengue NS1 rapid test, one is rabbit polyclonal antibody used for colloid gold conjugation, another is monoclonal antibody used for membrane coating. The dengue NS1 antigen rapid test developed by these two antibodies recognize all four subtype dengue NS1 antigen and with high sensitivity. For the detailed information, please check our dengue NS1 test product page.
4. New recombinant antigens
* Recombinant M. tuberculosis secreting P36 antigen used for M. . tuberculosis antibody test
* Recombinant feline leukemia virus P27 antigen
* Toxoplasma SAG1 and SAG2 antigens
5. Conjugate pad
* Dengue conjugate pad containsdengue 1 and 2 antigen available for dengue IgG/IgM rapid test.
6. Colloid gold
* High binding efficiency and high quality colloid gold available for your rapid test product(λ 529 to 533, OD 1.3 to 1.5)